Ziyue Wang

553 total citations
41 papers, 276 citations indexed

About

Ziyue Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Ziyue Wang has authored 41 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Ziyue Wang's work include Atrial Fibrillation Management and Outcomes (8 papers), Acute Ischemic Stroke Management (8 papers) and Traditional Chinese Medicine Analysis (3 papers). Ziyue Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Acute Ischemic Stroke Management (8 papers) and Traditional Chinese Medicine Analysis (3 papers). Ziyue Wang collaborates with scholars based in China, United States and Canada. Ziyue Wang's co-authors include Yingjie Zheng, Yining He, David D. McManus, Jane S. Saczynski, Molly E. Waring, Robert J. Goldberg, Saket Sanghai, Robert Hayward, Bo Tang and Qianyi Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Ziyue Wang

35 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyue Wang China 8 93 66 56 51 32 41 276
Lesley‐Jane Eales‐Reynolds United Kingdom 7 83 0.9× 61 0.9× 43 0.8× 35 0.7× 7 0.2× 15 346
Melissa Natavio United States 11 35 0.4× 39 0.6× 42 0.8× 32 0.6× 30 344
Gabriela Droc Romania 8 46 0.5× 36 0.5× 35 0.6× 17 0.3× 2 0.1× 56 316
Godfred Agongo Ghana 12 49 0.5× 35 0.5× 49 0.9× 4 0.1× 2 0.1× 29 293
Henry Christensen Denmark 11 25 0.3× 64 1.0× 57 1.0× 2 0.0× 7 0.2× 16 338
Saleh M. Al‐Qahtani Saudi Arabia 11 19 0.2× 76 1.2× 58 1.0× 3 0.1× 5 0.2× 36 300
Xiaowei Wu China 10 70 0.8× 142 2.2× 67 1.2× 3 0.1× 2 0.1× 17 563
Vesna Čukić Bosnia and Herzegovina 9 11 0.1× 37 0.6× 25 0.4× 5 0.1× 10 0.3× 23 288
Zhike Liu China 10 23 0.2× 50 0.8× 103 1.8× 10 0.2× 42 236
Giuseppe Sangiorgio Italy 9 24 0.3× 38 0.6× 48 0.9× 11 0.2× 4 0.1× 21 232

Countries citing papers authored by Ziyue Wang

Since Specialization
Citations

This map shows the geographic impact of Ziyue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyue Wang more than expected).

Fields of papers citing papers by Ziyue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyue Wang. The network helps show where Ziyue Wang may publish in the future.

Co-authorship network of co-authors of Ziyue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyue Wang. A scholar is included among the top collaborators of Ziyue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyue Wang. Ziyue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yunhe, Ziyue Wang, Yifei Du, et al.. (2025). Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities. Bioorganic & Medicinal Chemistry. 121. 118109–118109. 4 indexed citations
2.
Wang, Ziyue, et al.. (2025). Predictive and clinicopathological importance of HMGB2 in various carcinomas: a meta and bioinformatic approach. Scientific Reports. 15(1). 11003–11003. 1 indexed citations
3.
Wu, Ji, Ziyue Wang, Bingbing Chen, et al.. (2025). ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy. European Journal of Medicinal Chemistry. 291. 117646–117646. 4 indexed citations
5.
Wang, Ziyue, et al.. (2025). A Review of Current Research of Water Footprintsand Recommendations for Future Directions. Polish Journal of Environmental Studies. 1 indexed citations
6.
7.
Ji, Jianwei, et al.. (2025). Discovery of novel 1,2,3-triazole arylamide derivatives bearing dithiocarbamate moiety as dual inhibitors of tubulin and LSD1 with potent anticancer activity. European Journal of Medicinal Chemistry. 296. 117879–117879. 2 indexed citations
8.
Wang, Ziyue, et al.. (2024). Pharmacokinetics of Ziyuglycoside I and Ziyuglycoside II in Rat Plasma by UPLC-MS/MS. International Journal of Analytical Chemistry. 2024. 1–8. 4 indexed citations
9.
Xie, Xinxin, et al.. (2024). Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease. Brain Sciences. 14(3). 269–269. 6 indexed citations
10.
Wang, Ziyue, Denise Dunlap, Nathaniel Hafer, et al.. (2024). Point-of-care testing preferences 2020–2022: Trends over the years. PubMed. 5(3). 149–155.
11.
Wang, Ziyue, Anil Shrestha, Xiang Zhou, et al.. (2023). Exploring the Main Determinants of National Park Community Management: Evidence from Bibliometric Analysis. Forests. 14(9). 1850–1850. 6 indexed citations
12.
Ding, Eric, Khanh‐Van Tran, Darleen Lessard, et al.. (2023). Accuracy, Usability, and Adherence of Smartwatches for Atrial Fibrillation Detection in Older Adults After Stroke: Randomized Controlled Trial. JMIR Cardio. 7. e45137–e45137. 7 indexed citations
13.
Wang, Ziyue, et al.. (2023). Mismatch of MRI White Matter Hyperintensities and Gait Function in Patients With Cerebral Small Vessel Disease. Journal of Magnetic Resonance Imaging. 60(2). 550–558. 1 indexed citations
14.
Wang, Ziyue, et al.. (2022). HSP27 Protects Skin From Ultraviolet B -Induced Photodamage by Regulating Autophagy and Reactive Oxygen Species Production. Frontiers in Cell and Developmental Biology. 10. 852244–852244. 8 indexed citations
15.
Lilly, Craig M., Ziyue Wang, Denise Dunlap, et al.. (2022). 2021 Patient Preferences for Point of Care Testing Survey: More Acceptance and Less Concern. The Journal of Applied Laboratory Medicine. 7(6). 1302–1310. 2 indexed citations
16.
Ding, Eric, Nathaniel Erskine, Wim Stut, et al.. (2021). MI-PACE Home-Based Cardiac Telerehabilitation Program for Heart Attack Survivors: Usability Study. JMIR Human Factors. 8(3). e18130–e18130. 11 indexed citations
17.
Dunlap, Denise, Eric Ding, Ziyue Wang, et al.. (2021). Point-of-care testing, your cardiologist, and affairs of the heart. SHILAP Revista de lepidopterología. 2(6). 331–335. 6 indexed citations
18.
Bamgbade, Benita A., David D. McManus, Robert Helm, et al.. (2021). Differences in Perceived and Predicted Bleeding Risk in Older Adults With Atrial Fibrillation: The SAGE‐AF Study. Journal of the American Heart Association. 10(17). e019979–e019979. 6 indexed citations
19.
Ding, Eric, et al.. (2020). Mobile health assessments of geriatric elements in older patients with atrial fibrillation: The Mobile SAGE-AF Study (M-SAGE). SHILAP Revista de lepidopterología. 1(3). 123–129. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026